Literature DB >> 3150289

Cross-linking and new bone collagen synthesis in immobilized and recovering primate osteoporosis.

M Yamauchi1, D R Young, G S Chandler, G L Mechanic.   

Abstract

Quantification of collagen cross-links of monkey bone (tibia), from various time periods of immobilization (up to 7 months) and their subsequent reambulation (up to 40 months) was determined. Results indicated reducible cross-link concentrations markedly increased and peaked at the seven-month period of immobilization and returned to control values after 40 months of recovery. Chromatographic profiles of the major cross-linked peptides indicated that the increased cross-linking after seven months immobilization occurred between residue Hylald-16c as well as Lysald-16c of the alpha 1 chains and residue 87 Hyl of alpha chains of type I collagen. Mature, stable cross-link concentrations as well as their molecular loci remained constant throughout immobilization and reambulation. These results strongly suggest that rapid new bone collagen synthesis occurred during the osteoporotic state due to immobilization. With long-term recovery, the rate of collagen synthesis apparently returned to match the control bone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3150289     DOI: 10.1016/8756-3282(88)90124-x

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2006-08

2.  Bone fragility and collagen cross-links.

Authors:  Eleftherios P Paschalis; Elizabeth Shane; George Lyritis; Grigoris Skarantavos; Richard Mendelsohn; Adele L Boskey
Journal:  J Bone Miner Res       Date:  2004-08-30       Impact factor: 6.741

Review 3.  Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Authors:  Beatrice J Edwards; Andrew D Bunta; Joseph Lane; Clarita Odvina; D Sudhaker Rao; Dennis W Raisch; June M McKoy; Imran Omar; Steven M Belknap; Vishvas Garg; Allison J Hahr; Athena T Samaras; Matthew J Fisher; Dennis P West; Craig B Langman; Paula H Stern
Journal:  J Bone Joint Surg Am       Date:  2013-02-20       Impact factor: 5.284

4.  Decorin modulates collagen matrix assembly and mineralization.

Authors:  Yoshiyuki Mochida; Duenpim Parisuthiman; Suchaya Pornprasertsuk-Damrongsri; Phimon Atsawasuwan; Marnisa Sricholpech; Adele L Boskey; Mitsuo Yamauchi
Journal:  Matrix Biol       Date:  2008-11-18       Impact factor: 11.583

Review 5.  The effect of the microscopic and nanoscale structure on bone fragility.

Authors:  M E Ruppel; L M Miller; D B Burr
Journal:  Osteoporos Int       Date:  2008-03-04       Impact factor: 4.507

6.  Mineral composition is altered by osteoblast expression of an engineered G(s)-coupled receptor.

Authors:  G J Kazakia; D Speer; S Shanbhag; S Majumdar; B R Conklin; R A Nissenson; E C Hsiao
Journal:  Calcif Tissue Int       Date:  2011-04-28       Impact factor: 4.333

7.  FKBP65-dependent peptidyl-prolyl isomerase activity potentiates the lysyl hydroxylase 2-driven collagen cross-link switch.

Authors:  Yulong Chen; Masahiko Terajima; Priyam Banerjee; Houfu Guo; Xin Liu; Jiang Yu; Mitsuo Yamauchi; Jonathan M Kurie
Journal:  Sci Rep       Date:  2017-04-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.